Skip to main content

Advertisement

SpringerLink
Log in

Comprehensive evaluation of the incidence of late effects in 5-year survivors of breast cancer

  • Epidemiology
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Late effects of breast cancer affect the quality of survivorship. Using administrative data, we compared the occurrence of almost all ICD9 codes among older breast cancer survivors to that among a matched comparison cohort to generate new hypotheses. Breast cancer patients 65 years or older diagnosed 1990–1994 in 6 integrated care settings and who survived at least 5 years were matched with a cohort of women without a history of breast cancer on care setting, age, and calendar time. We collected data on the occurrence of incident ICD9 codes beginning 6 years after the breast cancer diagnosis date and continuing to year 15, and comparable data for the matched woman. We calculated hazard ratios (HRs) and 95 % confidence intervals associating breast cancer survivorship with incidence of each ICD9 code. We used semi-Bayes methods to address multiple comparisons. Older breast cancer survivors had about the same occurrence of diseases and conditions 6–15 years after breast cancer diagnosis as comparable women. The median of 564 adjusted HRs equaled 1.06, with interquartile range 0.92–1.3. The distribution of HRs pertaining to cancer-related ICD codes was shifted toward positive associations, and the distribution pertaining to cardiovascular-related ICD codes was shifted toward negative associations. In this hypothesis-scanning study, we observed little difference in the occurrence of non-breast cancer-related diseases and conditions among older, long-term breast cancer survivors, and comparable women without a history of breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Valdivieso M, Kujawa AM, Jones T, Baker LH (2012) Cancer survivors in the United States: a review of the literature and a call to action. Int J Med Sci 9(2):163–173. doi:10.7150/ijms.3827

    Article  PubMed Central  PubMed  Google Scholar 

  2. Ewertz M, Jensen AB (2011) Late effects of breast cancer treatment and potentials for rehabilitation. Acta Oncol 50(2):187–193. doi:10.3109/0284186X.2010.533190

    Article  PubMed  Google Scholar 

  3. Hooning MJ, Botma A, Aleman BM, Baaijens MH, Bartelink H, Klijn JG, Taylor CW, van Leeuwen FE (2007) Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst 99(5):365–375. doi:10.1093/jnci/djk064

    Article  PubMed  Google Scholar 

  4. Hickey M, Peate M, Saunders CM, Friedlander M (2009) Breast cancer in young women and its impact on reproductive function. Human Reprod Update 15(3):323–339. doi:10.1093/humupd/dmn064

    Article  CAS  Google Scholar 

  5. Taxel P, Choksi P, Van Poznak C (2012) The management of osteoporosis in breast cancer survivors. Maturitas 73(4):275–279. doi:10.1016/j.maturitas.2012.08.009

    Article  PubMed Central  PubMed  Google Scholar 

  6. Levangie PK, Drouin J (2009) Magnitude of late effects of breast cancer treatments on shoulder function: a systematic review. Breast Cancer Res Treat 116(1):1–15. doi:10.1007/s10549-008-0246-4

    Article  PubMed  Google Scholar 

  7. Lash TL, Silliman RA (2002) Long-term follow-up of upper-body function among breast cancer survivors. Breast J 8(1):28–33

    Article  PubMed  Google Scholar 

  8. Ganz PA, Guadagnoli E, Landrum MB, Lash TL, Rakowski W, Silliman RA (2003) Breast cancer in older women: quality of life and psychosocial adjustment in the 15 months after diagnosis. J Clin Oncol 21(21):4027–4033. doi:10.1200/JCO.2003.08.097

    Article  PubMed  Google Scholar 

  9. Raj KA, Marks LB, Prosnitz RG (2005) Late effects of breast radiotherapy in young women. Breast Dis 23:53–65

    PubMed  Google Scholar 

  10. de Ruiter MB, Reneman L, Boogerd W, Veltman DJ, Caan M, Douaud G, Lavini C, Linn SC, Boven E, van Dam FS, Schagen SB (2012) Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging. Hum Brain Mapp 33(12):2971–2983. doi:10.1002/hbm.21422

    Article  PubMed  Google Scholar 

  11. Abdulhaq H, Geyer C (2008) Safety of adjuvant endocrine therapy in postmenopausal women with breast cancer. Am J Clin Oncol 31(6):595–605. doi:10.1097/COC.0b013e31816d9171

    Article  PubMed  CAS  Google Scholar 

  12. Herrmann T, Gunther C, Csere P (2009) Localized morphea–a rare but significant secondary complication following breast cancer radiotherapy. Case report and review of the literature on radiation reaction among patients with scleroderma/morphea. Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft [et al] 185 (9):603–607. doi:10.1007/s00066-009-2051-3

  13. Canzler U, Schmidt-Gohrich UK, Bergmann S, Hanseroth K, Gatzweiler A, Distler W (2007) Syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by vinorelbine treatment of metastatic breast cancer. Onkologie 30(8–9):455–456. doi:10.1159/0000105143

    Article  PubMed  Google Scholar 

  14. Christensen S, Pedersen L, Grijota M, Kornum JB, Beiderbeck A, Sorensen HT (2008) Incidence of interstitial pneumonitis among breast cancer patients: a 10-year Danish population-based cohort study. Br J Cancer 98(11):1870–1875. doi:10.1038/sj.bjc.6604393

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  15. Enger SM, Thwin SS, Buist DS, Field T, Frost F, Geiger AM, Lash TL, Prout M, Yood MU, Wei F, Silliman RA (2006) Breast cancer treatment of older women in integrated health care settings. J Clin Oncol 24(27):4377–4383. doi:10.1200/JCO.2006.06.3065

    Article  PubMed Central  PubMed  Google Scholar 

  16. Clough-Gorr KM, Thwin SS, Bosco JL, Silliman RA, Buist DS, Pawloski PA, Quinn VP, Prout MN (2013) Incident malignancies among older long-term breast cancer survivors and an age-matched and site-matched nonbreast cancer comparison group over 10 years of follow-up. Cancer 119(8):1478–1485. doi:10.1002/cncr.27914

    Article  PubMed  Google Scholar 

  17. Haque R, Yood MU, Geiger AM, Kamineni A, Avila CC, Shi J, Silliman RA, Quinn VP (2011) Long-term safety of radiotherapy and breast cancer laterality in older survivors. Cancer Epidemiol Biomark Prev 20(10):2120–2126. doi:10.1158/1055-9965.EPI-11-0348

    Article  Google Scholar 

  18. Pawloski PA, Geiger AM, Haque R, Kamineni A, Fouayzi H, Ogarek J, Petersen HV, Bosco JL, Thwin SS, Silliman RA, Field TS (2013) Fracture risk in older, long-term survivors of early-stage breast cancer. J Am Geriatr Soc 61(6):888–895. doi:10.1111/jgs.12269

    Article  PubMed  Google Scholar 

  19. Wagner EH, Greene SM, Hart G, Field TS, Fletcher S, Geiger AM, Herrinton LJ, Hornbrook MC, Johnson CC, Mouchawar J, Rolnick SJ, Stevens VJ, Taplin SH, Tolsma D, Vogt TM (2005) Building a research consortium of large health systems: the Cancer Research Network. J Natl Cancer Inst Monogr 35:3–11. doi:10.1093/jncimonographs/lgi032

    Article  PubMed  Google Scholar 

  20. Thwin SS, Clough-Gorr KM, McCarty MC, Lash TL, Alford SH, Buist DS, Enger SM, Field TS, Frost F, Wei F, Silliman RA (2007) Automated inter-rater reliability assessment and electronic data collection in a multi-center breast cancer study. BMC Med Res Methodol 7:23

    Article  PubMed Central  PubMed  Google Scholar 

  21. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383

    Article  PubMed  CAS  Google Scholar 

  22. Steenland K, Bray I, Greenland S, Boffetta P (2000) Empirical Bayes adjustments for multiple results in hypothesis-generating or surveillance studies. Cancer Epidemiol Biomark Prev 9(9):895–903

    CAS  Google Scholar 

  23. Greenland S, Robins JM (1991) Empirical-Bayes adjustments for multiple comparisons are sometimes useful. Epidemiology 2:244–251

    Article  PubMed  CAS  Google Scholar 

  24. Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (2013) SEER Cancer Statistics Review, 1975–2010, based on November 2012 SEER data submission, posted to the SEER web site, April 2013 edn., Bethesda, MD

  25. Toriola AT, Colditz GA (2013) Trends in breast cancer incidence and mortality in the United States: implications for prevention. Breast Cancer Res Treat 138(3):665–673. doi:10.1007/s10549-013-2500-7

    Article  PubMed  Google Scholar 

  26. Maurea N, Coppola C, Ragone G, Frasci G, Bonelli A, Romano C, Iaffaioli RV (2010) Women survive breast cancer but fall victim to heart failure: the shadows and lights of targeted therapy. J Cardiovasc Med 11(12):861–868. doi:10.2459/JCM.0b013e328336b4c1

    Article  Google Scholar 

  27. Bradbury BD, Lash TL, Kaye JA, Jick SS (2005) Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina. Cancer 103(6):1114–1121. doi:10.1002/cncr.20900

    Article  PubMed  CAS  Google Scholar 

  28. Deimling GT, Sterns S, Bowman KF, Kahana B (2005) The health of older-adult, long-term cancer survivors. Cancer Nurs 28(6):415–424

    Article  PubMed  Google Scholar 

  29. Peuckmann V, Ekholm O, Rasmussen NK, Groenvold M, Christiansen P, Moller S, Eriksen J, Sjogren P (2009) Chronic pain and other sequelae in long-term breast cancer survivors: nationwide survey in Denmark. Eur J Pain 13(5):478–485. doi:10.1016/j.ejpain.2008.05.015

    Article  PubMed  CAS  Google Scholar 

  30. Dreyer NA, Garner S (2009) Registries for robust evidence. JAMA 302(7):790–791. doi:10.1001/jama.2009.1092

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Supported by Public Health Service grant R01CA093772-05A2 (Silliman, PI) from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services. The authors wish to thank Dr. Marianne Prout for her assistance with categorizing individual ICD9 codes into disease groups. This manuscript was prepared while Dr. Geiger was employed at Wake Forest School of Medicine. The opinions expressed in this article are the author’s own and do not reflect the view of the National Institutes of Health, the Department of Health and Human Services, or the United States government.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Epidemiology, Rollins School of Public Health, Emory University, 1518 Clifton Rd, Atlanta, GA, 30322, USA

    Timothy L. Lash

  2. Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Healthcare System, Boston, MA, USA

    Soe Soe Thwin

  3. Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA

    Marianne Ulcickas Yood

  4. Health Services and Economics Branch, Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA

    Ann M. Geiger

  5. Real-World & Late Phase Research Division of Quintiles, Inc., Cambridge, MA, USA

    Jaclyn Bosco

  6. Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA

    Virginia P. Quinn

  7. Meyers Primary Care Institute, Worcester, MA, USA

    Terry S. Field

  8. HealthPartners Institute for Education and Research, Minneapolis, MN, USA

    Pamala A. Pawloski

  9. Section of Geriatrics, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA

    Rebecca A. Silliman

Authors
  1. Timothy L. Lash
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Soe Soe Thwin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marianne Ulcickas Yood
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ann M. Geiger
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jaclyn Bosco
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Virginia P. Quinn
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Terry S. Field
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Pamala A. Pawloski
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Rebecca A. Silliman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Timothy L. Lash.

Appendix

Appendix

See Table 2

Table 2 Frequencies and HRs for included ICD9 codes, sorted by ICD9 code
Full size table

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lash, T.L., Thwin, S.S., Yood, M.U. et al. Comprehensive evaluation of the incidence of late effects in 5-year survivors of breast cancer. Breast Cancer Res Treat 144, 643–663 (2014). https://doi.org/10.1007/s10549-014-2885-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-014-2885-y

Keywords

Search

Navigation